Insider · CIK 0001301572
Ted A Dosch
Files at UGI (UGI CORP /PA/). First filing -, latest -.
In brief
Ted A Dosch files SEC Form 4 as director at UGI (UGI CORP /PA/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ted A Dosch has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | UGI UGI CORP /PA/ | AGrant or award UGI Common Stockindirect: Benefit Plan | +4,364 | $0.00 | $0 | 36,096 | Feb 3, 2026 |
| Jan 31, 2025 | UGI UGI CORP /PA/ | AGrant or award UGI Common Stockindirect: Benefit Plan | +5,695 | $0.00 | $0 | 30,509 | Feb 4, 2025 |
| Jan 26, 2024 | UGI UGI CORP /PA/ | AGrant or award UGI Common Stockindirect: Benefit Plan | +4,470 | $0.00 | $0 | 23,562 | Jan 30, 2024 |
| Jan 26, 2024 | UGI UGI CORP /PA/ | AGrant or award Options (Right to Buy)derivative | +12,890 | $0.00 | $0 | 12,890 | Jan 30, 2024 |
Questions about Ted A Dosch
Answered from the filings on this page, as of the latest one.
Is Ted A Dosch buying or selling?
Ted A Dosch has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ted A Dosch's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ted A Dosch has 0.
Where does Ted A Dosch file Form 4?
Ted A Dosch has filed Form 4 at UGI (UGI CORP /PA/). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.